Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia
Clinical trial NCT03071276 · TERMINATED
Trial details
- NCT number
- NCT03071276
- Sponsor
- St. Jude Children's Research Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-14
- Primary completion
- 2019-04-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.